Theranos has struggled behind the scenes to turn the excitement over its technology into reality. At the end of 2014, the lab instrument developed as the linchpin of its strategy handled just a small fraction of the tests then sold to consumers, according to four former employees.
Calling all HuffPost superfans!
Sign up for membership to become a founding member and help shape HuffPost's next chapter
Read more on The Wall Street Journal
